End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.79 CNY | +0.35% | -2.15% | +23.59% |
04-29 | Kanghong Pharmaceutical's Unit Gets US FDA's Green Light to Test Macular Degeneration Drug | MT |
04-29 | Kanghong Pharmaceutical's Unit Gets Nod to Trial Macular Degeneration Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+23.59% | 2.89B | |
+34.35% | 693B | |
+29.39% | 584B | |
-3.49% | 372B | |
+20.15% | 332B | |
+6.19% | 294B | |
+14.11% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+9.21% | 168B |
- Stock Market
- Equities
- 002773 Stock
- News Chengdu Kanghong Pharmaceutical Group Co., Ltd
- Kanghong Pharmaceutical's Mosapride Citrate Tablets Wins Centralized Procurement Bid